查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1479990

心臟安全服務市場評估：依類型、應用、最終用戶和地區劃分的機會和預測（2017-2031）

Cardiac Safety Services Market Assessment, By Type, By Application Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 220 Pages | 商品交期: 3-5個工作天內

價格

全球心臟安全服務市場規模將從 2023 年的 7.5323 億美元增長到 2031 年的 16.3825 億美元，預計在 2024-2031 年期間複合年增長率將達到 10.2%。

市場近年來取得了顯著的成長，預計未來將保持穩定的擴張速度。 心臟安全服務是指醫療專業人員使用的設備來檢測與心臟相關的任何可能的故障風險並預防嚴重問題或致命情況。 這些服務包括心電圖、血壓監測、MUGA 掃瞄、長期動態心電圖監測等。

預計心臟安全服務市場在未來幾年將出現混合成長。 人口老化的加劇、技術的進步、人們對定期健康檢查的意識以及總體人口的成長是該市場具有成長潛力的部分原因。 醫療保健提供者和行業領導者正在合作，為患者提供最佳的診斷方法。 政府機構和私人公司已籌集資金並進行大量投資。 心血管疾病盛行率的增加預計也將推動市場的成長。 根據世界衛生組織 (WHO) 2022 年 10 月更新的統計數據，過去 17 年中，終生中風風險增加了 50%，估計有四分之一的人在一生中會經歷中風。

心血管疾病盛行率增加：

心臟病、心律不整和心臟衰竭是心血管疾病 (CVD) 的例子，心血管疾病是全世界發病和死亡的主要原因。 由於這些疾病的發生率不斷增加，快速乾預和治療計劃依賴心電圖 (ECG) 等精密診斷儀器。 世界人口的老化增加了人們罹患心血管疾病的可能性，凸顯了對診斷心電圖設備的需求，以正確監測和管理心臟健康。 隨著年齡的增長，我們變得更容易患上心臟相關疾病，因此始終需要先進的診斷設備來提供準確的讀數並在嚴重問題發生之前預防它們。 由於技術的不斷改進，心電圖設備的準確性、易用性和連接性都在不斷提高。 無線監測、基於雲端的資料儲存和行動應用程式的引入增加了心電圖設備在家庭護理和臨床環境中的使用。 這些發展使醫療保健專業人員能夠遠端監測患者的心臟狀態並及時進行幹預，從而改善患者的整體治療結果。 此外，發展中國家正在大力投資醫療基礎設施，包括建造診斷中心。 除了改善醫療保健服務的取得之外，此類基礎設施還提供了對更廣泛設備的更多存取。 這些發展尤其重要，因為它們將有助於縮小醫療差距，並提高醫療技術有限地區弱勢群體的照護水準。 根據世界衛生組織的報告，全世界每年有 1,790 萬人因心血管疾病 (CVD) 死亡，成為死亡的主要原因。 心臟和血管疾病稱為CVD，包括風濕性心臟病、冠狀動脈心臟病和腦血管疾病。 心臟病發作和中風佔五分之四以上的 CVD 死亡病例，其中三分之一的死亡發生在 70 歲以下的早期人群中。

心臟安全服務的技術進步：

由於技術進步改善了疾病檢測和治療，診斷設備的銷售大幅成長。 這些儀器採用了最新技術，以提高便攜性、靈活性和工作流程，使醫生能夠在檢查期間輕鬆調整工作站。 各種管理解決方案的供應商都渴望推進數位化，以改善數據通信，並實現與其他軟體系統（例如雲端和智慧型手機系統）更廣泛的存取和互通性。 心臟安全服務市場預計將受到新治療方法和技術改進的推動。

本報告調查了全球心臟安全服務市場，提供了市場定義和概述、市場規模趨勢和預測、各個細分市場/地區/主要國家的詳細分析、行業結構和市場成長趨勢，其中包括影響因素分析。

目錄

第一章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第四章全球心臟安全服務市場展望

  • 市場規模/預測
  • 依類型
    • 綜合服務
    • 獨立服務
  • 依用途
    • 心電圖/動態心電圖測量服務
    • 血壓測量服務
    • 心血管影像服務
    • 完善的 QT 服務
    • 其他
  • 依最終用戶
    • 製藥和生物製藥公司
    • 合約研究組織
    • 學術/研究機構
  • 依地區
    • 北美
    • 歐洲
    • 南美洲
    • 亞太地區
    • 中東/非洲
  • 各公司的市佔率

第 6 章全球心臟安全服務市場展望：依地區

  • 北美
  • 歐洲
  • 南美洲
  • 亞太地區
  • 中東/非洲

第 6 章市場映射

  • 依類型
  • 依用途
  • 依最終用戶
  • 依地區

第七章宏觀環境/產業結構

  • 需求與供給分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市場動態

  • 生長促進因素
  • 生長抑制因子（問題/限制）

第 9 章創新/新興科技

第十章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析
  • 併購/合資企業（如果適用）
  • SWOT 分析（5 家參與公司）
  • 專利分析（如果適用）

第 11 章案例研究

第十二章主要公司展望

  • Laboratory Corporation of America Holdings
  • Medpace Holdings, Inc.
  • Koninklijke Philips N.V.
  • Clario
  • Ncardia Services B.V.
  • IQVIA Holdings, Inc.
  • Certara, Inc.
  • ICON PLC.
  • WuXi Biologics Cayman Inc.
  • Eurofins Biopharma Product Testing India Pvt Ltd

第 13 章策略建議

第14章關於我們公司/免責聲明

Product Code: MX11335

Global cardiac safety services market is projected to witness a CAGR of 10.2% during the forecast period 2024-2031, growing from USD 753.23 million in 2023 to USD 1638.25 million by 2031. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years. Cardiac safety services are devices that are used by healthcare professionals to detect the risk of any possible heart-related malfunctions to prevent any major problems or conditions that may be fatal. These services include ECG, blood pressure monitoring, multi-gated acquisition scans, long-term Holter monitoring, and more tests.

Cardiac safety services market is expected to grow manifold in the coming years. A rising geriatric population, technological advancements, awareness among people about getting regular health check-ups, and an overall increasing population are a few reasons why this market has the potential to grow. Healthcare providers and industry giants are coming together to bring out their best diagnostic approaches for patients. Funds are being raised, and a hefty amount is being invested by both governmental bodies as well as private companies. Strategic movements like acquisitions and mergers, investments, and partnerships come into play when these huge companies are trying to launch or develop a new product. This market holds significant importance because of how important it is to diagnose the root causes of any heart-related condition beforehand to avoid serious outcomes. Additionally, it is anticipated that the growing incidence of cardiovascular illnesses will support the segment's expansion. Statistics updated by the World Health Organisation, in October 2022, show that the lifetime risk of stroke has risen by 50% in the past 17 years, with an estimated 1 in 4 people expected to experience a stroke in their lifetime.

Rising Prevalence of Cardiovascular Diseases

Heart attacks, arrhythmias, and heart failure are examples of cardiovascular diseases (CVDs), which are leading causes of morbidity and mortality globally. Owing to the rising incidence of these disorders, prompt intervention and treatment planning depend on precise diagnostic instruments like electrocardiograms (ECGs). The aging population of the world emphasizes the necessity of diagnostic ECG devices in order to properly monitor and manage heart health because of their increased vulnerability to cardiovascular issues. People are becoming more susceptible to heart-related conditions as they get older, which means there will always be a need for advanced diagnostic equipment that can give precise readings and prevent any major issues. The accuracy, usability, and connectivity aspects of ECG equipment have all improved as a result of ongoing technical improvements. The use of ECG devices in home care and clinical settings has increased with the incorporation of wireless monitoring, cloud-based data storage, and mobile applications. These developments improve patient outcomes overall by enabling medical practitioners to remotely monitor patients' cardiac conditions and enable timely intervention. Moreover, developing nations are investing heavily in the infrastructure of healthcare, including the construction of diagnostic centers. In addition to facilitating better access to healthcare services, this infrastructural development opens possibilities for the broad use of various equipment. These developments are especially important since they close the gap in healthcare disparities and raise the standard of care for marginalized communities in places where access to medical technologies was previously restricted. According to a report by the WHO, globally, cardiovascular diseases (CVDs) account for 17.9 million deaths annually, making them the leading cause of death. Heart and blood vessel illnesses, together referred to as CVDs, include rheumatic heart disease, coronary heart disease, and cerebrovascular disease. Heart attacks and strokes account for more than four out of every five deaths from CVD, and one-third of these deaths happen too soon among those under the age of 70.

Technological Advancements in Cardiac Safety Services

The sales of diagnostic equipment have expanded significantly as a result of advanced technology, improving disease detection and treatment. The latest technologies are now included with these devices to improve portability, flexibility, and workflow, allowing doctors to easily adjust workstations during exams. Vendors of various management solutions have been motivated by the ongoing digitalization to improve data communication, allowing for wider access and interoperability with other software systems, such as cloud and smartphone systems. Well-known manufacturers are committed to offering cutting-edge features and applications for their diagnostic machines, including GE Healthcare's CASE exercise testing system. The cardiac safety services market will be driven by new therapeutic approaches and technological improvements. With the use of the Exercise Testing System, ambulatory ECG, pacemaker, Holter monitor, and event monitor, it is now possible to effectively treat the increasing number of instances of arrhythmia, cardiomyopathy, and coronary artery disease. In the US, pacemakers are implanted in almost 2.6 out of every 1000 people to address a variety of heart diseases, according to an NCBI study. The elderly are more likely to use pacemakers than other age groups: 0.4 out of 1000 persons in the 18-64 age group and 26 out of 1000 people in the 65+ age group use pacemakers.

Increasing Demand for ECG/Holter Measurement Segment

A Holter monitor is a battery-operated portable ECG device that can be worn by a patient for 24 to 48 hours, records heart activity (electrocardiogram) continuously, and monitors the heart rhythm. Patients and doctors are using this portable ECG equipment more frequently because it has various benefits over standard ECG devices, including fewer leads and the ability to allow the patient to move around and go about their regular daily activities. Segment growth is anticipated to be aided by the growing geriatric population and the rising incidence of cardiovascular diseases.

The American Heart Association published its data in December 2022, which showed older patients had more pronounced anatomical changes and more severe functional impairment during heart diseases. Aging-related cardiovascular changes also increase the risk of acute coronary syndrome (ACS) and may complicate its diagnosis and treatment. It occurs because big arteries experience blockage with age. The heart muscle pumps less effectively, even if it works harder, due to blockage. Therefore, it is anticipated that the use of ECG/Holter measurement services will increase due to the growing problems of cardiovascular diseases with aging. A groundbreaking 12-lead ECG-integrated solution for at-home use in decentralized clinical trials was revealed by Koninklijke Philips in January 2022. This innovation aims to reduce the need for, and burden associated with traditional clinical trials, thereby improving patient retention, compliance, and trial outcomes.

North America to Dominate the Cardiac Safety Services Market

Due to the rising number of elderly patients and the high incidence of cardiovascular illnesses, North America is anticipated to account for a sizable portion of the global market for cardiac safety services throughout the projection period.

For example, the Center for Disease Control and Prevention (CDC) updated its data in October 2022 and estimated that approximately 805,000 Americans experience a heart attack annually, of which 605,000 are estimated to be first-time heart attack victims and 200,000 are heart attack survivors. Additionally, it is anticipated that the region's aging population will raise the prevalence of cardiovascular illnesses, which will increase the use of cardiac safety services. In July 2022, Statistics Canada released data projecting that 7,330,605 Canadians, 65 years of age or older, comprise 18.8%

of the country's overall population. AliveCor unveiled the KardiaMobileCard in February 2022, which is the most practical and svelte personal electrocardiogram (PECG) device in the US market. It is the only portable ECG device that is small enough to put in a wallet and offers real-time, anytime, anywhere heart health information.

Future Market Scenario (2024-2031F)

The rising prevalence of cardiovascular diseases in the population is one of the biggest reasons why the cardiac safety services market is expected to grow in the forecast period. Heart attacks are shown to be the most widespread among all and are very common, which raises concern and hence requires a quick diagnosis. Technology and diagnostic approaches that are effective and cost-efficient are being introduced by players in this industry who are growing at an unmatched pace. The government is taking initiatives, bringing in new policies, and raising funds to improve the shape of healthcare around the globe. Clario (US) and Dr. Vince Clinical Research (DVCR) (US) partnered in August 2023 to deliver innovative cardiac assessments in clinical trials. Clario (US) can provide precise and economical cardiac safety data early in the clinical development process thanks to the strategic partnership.

Key Players Landscape and Outlook

Several companies such as Laboratory Corporation of America Holdings, Medpace Holdings, Inc., Koninklijke Philips N.V., Clario, Ncardia Services B.V., IQVIA Holdings, Inc., Certara, Inc., ICON PLC., WuXi Biologics Cayman Inc., Eurofins Scientific SE are expanding their businesses by planning and adopting new strategies. They are complying with the new strategic initiatives regarding the launches of newly developed cardiac safety devices to increase their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways through which they are trying to achieve the same.

FIFPRO and IDOVEN established a strategic partnership in August 2022 with the aim of enhancing player health protections against cardiac arrest and other heart-related hazards. Novocardia introduced a novel heart failure programme in May 2022 that improves the lives of heart failure patients and reduces the need for hospital stays by combining remote patient monitoring with individualized health coaching.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Cardiac Safety Services Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
  • 4.2.By Type
    • 4.2.1.Integrated Services
    • 4.2.2.Standalone Services
  • 4.3.By Application Type
    • 4.3.1.ECG/Holter Measurement Services
    • 4.3.2.Blood Pressure Measurement Services
    • 4.3.3.Cardiovascular Imaging Services
    • 4.3.4.Thorough QT Services
    • 4.3.5.Others
  • 4.4.By End-user
    • 4.4.1.Pharmaceutical and Biopharmaceutical Companies
    • 4.4.2.Contract Research Organizations
    • 4.4.3.Academic and Research Institutes
  • 4.5.By Region
    • 4.5.1.North America
    • 4.5.2.Europe
    • 4.5.3.Asia-Pacific
    • 4.5.4.South America
    • 4.5.5.Middle East and Africa
  • 4.6.By Company Market Share (%), 2023

5.Global Cardiac Safety Services Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
    • 5.1.2.By Type
      • 5.1.2.1.Integrated Services
      • 5.1.2.2.Standalone Services
    • 5.1.3.By Application Type
      • 5.1.3.1.ECG/Holter Measurement Services
      • 5.1.3.2.Blood Pressure Measurement Services
      • 5.1.3.3.Cardiovascular Imaging Services
      • 5.1.3.4.Thorough QT Services
      • 5.1.3.5.Others
    • 5.1.4.By End-user
      • 5.1.4.1.Pharmaceutical and Biopharmaceutical Companies
      • 5.1.4.2.Contract Research Organizations
      • 5.1.4.3.Academic and Research Institutes
    • 5.1.5.United States*
      • 5.1.5.1.Market Size & Forecast
        • 5.1.5.1.1.By Value
      • 5.1.5.2.By Type
        • 5.1.5.2.1.Integrated Services
        • 5.1.5.2.2.Standalone Services
      • 5.1.5.3.By Application Type
        • 5.1.5.3.1.ECG/Holter Measurement Services
        • 5.1.5.3.2.Blood Pressure Measurement Services
        • 5.1.5.3.3.Cardiovascular Imaging Services
        • 5.1.5.3.4.Thorough QT Services
        • 5.1.5.3.5.Others
      • 5.1.5.4.By End-user
        • 5.1.5.4.1.Pharmaceutical and Biopharmaceutical Companies
        • 5.1.5.4.2.Contract Research Organizations
        • 5.1.5.4.3.Academic and Research Institutes
    • 5.1.6.Canada
    • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East and Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Type
  • 6.2.By Application
  • 6.3.By Technology
  • 6.4.By End-user
  • 6.5.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Value Chain Analysis
  • 7.3.PESTEL Analysis
    • 7.3.1.Political Factors
    • 7.3.2.Economic System
    • 7.3.3.Social Implications
    • 7.3.4.Technological Advancements
    • 7.3.5.Environmental Impacts
    • 7.3.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.4.Porter's Five Forces Analysis
    • 7.4.1.Supplier Power
    • 7.4.2.Buyer Power
    • 7.4.3.Substitution Threat
    • 7.4.4.Threat From New Entrant
    • 7.4.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Case Studies

12.Key Players Outlook

  • 12.1.Laboratory Corporation of America Holdings
    • 12.1.1.Company Details
    • 12.1.2.Key Management Personnel
    • 12.1.3.Products and Services
    • 12.1.4.Financials (As reported)
    • 12.1.5.Key Market Focus and Geographical Presence
    • 12.1.6.Recent Developments
  • 12.2.Medpace Holdings, Inc.
  • 12.3.Koninklijke Philips N.V.
  • 12.4.Clario
  • 12.5.Ncardia Services B.V.
  • 12.6.IQVIA Holdings, Inc.
  • 12.7.Certara, Inc.
  • 12.8.ICON PLC.
  • 12.9.WuXi Biologics Cayman Inc.
  • 12.10.Eurofins Biopharma Product Testing India Pvt Ltd

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

13.Strategic Recommendations

14.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 2.Global Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 3.Global Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 4.Global Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 5.Global Cardiac Safety Services Market Share (%), By Region, 2017-2031F
  • Figure 6.North America Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 7.North America Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 8.North America Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 9.North America Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 10.North America Cardiac Safety Services Market Share (%), By Country, 2017-2031F
  • Figure 11.United States Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 12.United States Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 13.United States Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 14.United States Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 15.Canada Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 16.Canada Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 17.Canada Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 18.Canada Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 19.Mexico Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 20.Mexico Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 21.Mexico Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 22.Mexico Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 23.Europe Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 24.Europe Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 25.Europe Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 26.Europe Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 27.Europe Cardiac Safety Services Market Share (%), By Country, 2017-2031F
  • Figure 28.Germany Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 29.Germany Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 30.Germany Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 31.Germany Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 32.France Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 33.France Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 34.France Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 35.France Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 36.Italy Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 37.Italy Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 38.Italy Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 39.Italy Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 40.United Kingdom Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 41.United Kingdom Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 42.United Kingdom Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 43.United Kingdom Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 44.Russia Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 45.Russia Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 46.Russia Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 47.Russia Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 48.Netherlands Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 49.Netherlands Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 50.Netherlands Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 51.Netherlands Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 52.Spain Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 53.Spain Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 54.Spain Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 55.Spain Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 56.Turkey Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 57.Turkey Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 58.Turkey Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 59.Turkey Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 60.Poland Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 61.Poland Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 62.Poland Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 63.Poland Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 64.South America Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 65.South America Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 66.South America Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 67.South America Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 68.South America Cardiac Safety Services Market Share (%), By Country, 2017-2031F
  • Figure 69.Brazil Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 70.Brazil Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 71.Brazil Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 72.Brazil Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 73.Argentina Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 74.Argentina Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 75.Argentina Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 76.Argentina Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 77.Asia-Pacific Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 78.Asia-Pacific Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 79.Asia-Pacific Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 80.Asia-Pacific Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 81.Asia-Pacific Cardiac Safety Services Market Share (%), By Country, 2017-2031F
  • Figure 82.India Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 83.India Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 84.India Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 85.India Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 86.China Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 87.China Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 88.China Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 89.China Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 90.Japan Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 91.Japan Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 92.Japan Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 93.Japan Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 94.Australia Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 95.Australia Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 96.Australia Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 97.Australia Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 98.Vietnam Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 99.Vietnam Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 100.Vietnam Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 101.Vietnam Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 102.South Korea Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 103.South Korea Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 104.South Korea Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 105.South Korea Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 106.Indonesia Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 107.Indonesia Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 108.Indonesia Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 109.Indonesia Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 110.Philippines Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 111.Philippines Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 112.Philippines Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 113.Philippines Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 114.Middle East & Africa Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 115.Middle East & Africa Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 116.Middle East & Africa Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 117.Middle East & Africa Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 118.Middle East & Africa Cardiac Safety Services Market Share (%), By Country, 2017-2031F
  • Figure 119.Saudi Arabia Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 120.Saudi Arabia Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 121.Saudi Arabia Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 122.Saudi Arabia Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 123.UAE Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 124.UAE Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 125.UAE Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 126.UAE Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 127.South Africa Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
  • Figure 128.South Africa Cardiac Safety Services Market Share (%), By Type, 2017-2031F
  • Figure 129.South Africa Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
  • Figure 130.South Africa Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
  • Figure 131.By Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 132.By Application Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 133.By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 134.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023